Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Thompson

Showing results (91-100 of 125) with videos related to

Pageof 13
Sort By:
Gene Therapy|April 23, 2011
Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer modelK Tabata, S Kurosaka, M Watanabe, et al.
Cancer|February 1, 1993
Transgenic models for the study of prostate cancerT C Thompson, L D Truong, T L Timme, et al.
Oncogene|March 2, 1995
Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancerT C Thompson, S H Park, T L Timme, et al.
Prostate Cancer and Prostatic Diseases|March 11, 2003
Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promotersS Ebara, S Shimura, Y Nasu, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1992
Transforming growth factor beta 1 as a biomarker for prostate cancerT C Thompson, L D Truong, T L Timme, et al.
British Journal of Cancer|October 26, 2013
Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expressionX Tan, Y Wang, Y Han, et al.
The Journal of Urology|May 1, 1994
Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological featuresD R Greene, E Rogers, E C Wessels, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoterC Pramudji, S Shimura, S Ebara, et al.
Cancer Research|June 5, 2001
Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cellsL Li, G Yang, S Ebara, et al.
Nature Medicine|September 12, 1998
Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cellsY Nasu, T L Timme, G Yang, et al.
Pageof 13

Showing results (91-100 of 125) with videos related to

Sort By:
Pageof 13
Gene Therapy|April 23, 2011
Tumor growth and metastasis suppression by Glipr1 gene-modified macrophages in a metastatic prostate cancer modelK Tabata, S Kurosaka, M Watanabe, et al.
Cancer|February 1, 1993
Transgenic models for the study of prostate cancerT C Thompson, L D Truong, T L Timme, et al.
Oncogene|March 2, 1995
Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancerT C Thompson, S H Park, T L Timme, et al.
Prostate Cancer and Prostatic Diseases|March 11, 2003
Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promotersS Ebara, S Shimura, Y Nasu, et al.
Journal of Cellular Biochemistry. Supplement|January 1, 1992
Transforming growth factor beta 1 as a biomarker for prostate cancerT C Thompson, L D Truong, T L Timme, et al.
British Journal of Cancer|October 26, 2013
Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expressionX Tan, Y Wang, Y Han, et al.
The Journal of Urology|May 1, 1994
Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological featuresD R Greene, E Rogers, E C Wessels, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2001
In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoterC Pramudji, S Shimura, S Ebara, et al.
Cancer Research|June 5, 2001
Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cellsL Li, G Yang, S Ebara, et al.
Nature Medicine|September 12, 1998
Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer cellsY Nasu, T L Timme, G Yang, et al.
Pageof 13